383 related articles for article (PubMed ID: 1351371)
21. Intermittent trimethoprim-sulfamethoxazole compared with dapsone-pyrimethamine for the simultaneous primary prophylaxis of Pneumocystis pneumonia and toxoplasmosis in patients infected with HIV.
Podzamczer D; Salazar A; Jiménez J; Consiglio E; Santín M; Casanova A; Rufí G; Gudiol F
Ann Intern Med; 1995 May; 122(10):755-61. PubMed ID: 7717598
[TBL] [Abstract][Full Text] [Related]
22. Primary prophylaxis for Pneumocystis carinii pneumonia: a randomized trial comparing cotrimoxazole, aerosolized pentamidine and dapsone plus pyrimethamine.
Mallolas J; Zamora L; Gatell JM; Miró JM; Vernet E; Valls ME; Soriano E; SanMiguel JG
AIDS; 1993 Jan; 7(1):59-64. PubMed ID: 8442918
[TBL] [Abstract][Full Text] [Related]
23. Prophylaxis for Pneumocystis carinii pneumonia in patients infected with human immunodeficiency virus.
Kovacs JA; Masur H
Clin Infect Dis; 1992 May; 14(5):1005-9. PubMed ID: 1350925
[TBL] [Abstract][Full Text] [Related]
24. Effect of zidovudine and Pneumocystis carinii pneumonia prophylaxis on progression of HIV-1 infection to AIDS. The Multicenter AIDS Cohort Study.
Graham NM; Zeger SL; Park LP; Phair JP; Detels R; Vermund SH; Ho M; Saah AJ
Lancet; 1991 Aug; 338(8762):265-9. PubMed ID: 1677108
[TBL] [Abstract][Full Text] [Related]
25. Risk of toxoplasmic encephalitis in AIDS patients: indications for prophylaxis.
Dunlop O; Rootwelt V; Sannes M; Goplen AK; Abdelnoor M; Skaug K; Baklien K; Skar A; Melby K; Myrvang B; Bruun JN
Scand J Infect Dis; 1996; 28(1):71-3. PubMed ID: 9122637
[TBL] [Abstract][Full Text] [Related]
26. Trimethoprim-sulfamethoxazole compared with pentamidine for treatment of Pneumocystis carinii pneumonia in the acquired immunodeficiency syndrome. A prospective, noncrossover study.
Sattler FR; Cowan R; Nielsen DM; Ruskin J
Ann Intern Med; 1988 Aug; 109(4):280-7. PubMed ID: 3260759
[TBL] [Abstract][Full Text] [Related]
27. A randomized trial of three antipneumocystis agents in patients with advanced human immunodeficiency virus infection. NIAID AIDS Clinical Trials Group.
Bozzette SA; Finkelstein DM; Spector SA; Frame P; Powderly WG; He W; Phillips L; Craven D; van der Horst C; Feinberg J
N Engl J Med; 1995 Mar; 332(11):693-9. PubMed ID: 7854375
[TBL] [Abstract][Full Text] [Related]
28. Oral therapy for Pneumocystis carinii pneumonia in the acquired immunodeficiency syndrome. A controlled trial of trimethoprim-sulfamethoxazole versus trimethoprim-dapsone.
Medina I; Mills J; Leoung G; Hopewell PC; Lee B; Modin G; Benowitz N; Wofsy CB
N Engl J Med; 1990 Sep; 323(12):776-82. PubMed ID: 2392131
[TBL] [Abstract][Full Text] [Related]
29. From the Centers for Disease Control. Guidelines for prophylaxis against Pneumocystis carinii pneumonia for persons infected with human immunodeficiency virus.
JAMA; 1989 Jul; 262(3):335-9. PubMed ID: 2525628
[No Abstract] [Full Text] [Related]
30. Primary prophylaxis with pyrimethamine for toxoplasmic encephalitis in patients with advanced human immunodeficiency virus disease: results of a randomized trial. Terry Beirn Community Programs for Clinical Research on AIDS.
Jacobson MA; Besch CL; Child C; Hafner R; Matts JP; Muth K; Wentworth DN; Neaton JD; Abrams D; Rimland D
J Infect Dis; 1994 Feb; 169(2):384-94. PubMed ID: 8106772
[TBL] [Abstract][Full Text] [Related]
31. Impact of primary prophylaxis for Pneumocystis carinii pneumonia and toxoplasmic encephalitis in a cohort of 1000 patients with AIDS.
Monforte AD; Mainini F; Bini T; Moscatelli GC; Antinori S; Formenti T; Testa L; Mena M; Moroni M
J Chemother; 1995 Nov; 7 Suppl 4():184-6. PubMed ID: 8904150
[No Abstract] [Full Text] [Related]
32. Randomized study of sulfamethoxazole-trimethoprim versus aerosolized pentamidine for secondary prophylaxis of Pneumocystis carinii pneumonia in patients with AIDS.
Nielsen TL; Jensen BN; Nelsing S; Mathiesen LR; Skinhøj P; Nielsen JO
Scand J Infect Dis; 1995; 27(3):217-20. PubMed ID: 8539544
[TBL] [Abstract][Full Text] [Related]
33. Trimethoprim-sulfamethoxazole or pentamidine for Pneumocystis carinii pneumonia in the acquired immunodeficiency syndrome. A prospective randomized trial.
Wharton JM; Coleman DL; Wofsy CB; Luce JM; Blumenfeld W; Hadley WK; Ingram-Drake L; Volberding PA; Hopewell PC
Ann Intern Med; 1986 Jul; 105(1):37-44. PubMed ID: 3521428
[TBL] [Abstract][Full Text] [Related]
34. Preventing toxoplasmic encephalitis in persons infected with human immunodeficiency virus.
Richards FO; Kovacs JA; Luft BJ
Clin Infect Dis; 1995 Aug; 21 Suppl 1():S49-56. PubMed ID: 8547512
[TBL] [Abstract][Full Text] [Related]
35. Discontinuation of primary prophylaxis against Pneumocystis carinii pneumonia in HIV-1-infected adults treated with combination antiretroviral therapy. Swiss HIV Cohort Study.
Furrer H; Egger M; Opravil M; Bernasconi E; Hirschel B; Battegay M; Telenti A; Vernazza PL; Rickenbach M; Flepp M; Malinverni R
N Engl J Med; 1999 Apr; 340(17):1301-6. PubMed ID: 10219064
[TBL] [Abstract][Full Text] [Related]
36. A meta-analysis of the relative efficacy and toxicity of Pneumocystis carinii prophylactic regimens.
Ioannidis JP; Cappelleri JC; Skolnik PR; Lau J; Sacks HS
Arch Intern Med; 1996 Jan; 156(2):177-88. PubMed ID: 8546551
[TBL] [Abstract][Full Text] [Related]
37. Effectiveness of twice-weekly pyrimethamine-sulfadoxine as primary prophylaxis of Pneumocystis carinii pneumonia and toxoplasmic encephalitis in patients with advanced HIV infection.
Schürmann D; Bergmann F; Albrecht H; Padberg J; Wünsche T; Grünewald T; Schürmann M; Grobusch M; Vallée M; Ruf B; Suttorp N
Eur J Clin Microbiol Infect Dis; 2002 May; 21(5):353-61. PubMed ID: 12072919
[TBL] [Abstract][Full Text] [Related]
38. Treatment of Pneumocystis carinii pneumonia in patients with AIDS.
Wordell CJ; Hauptman SP
Clin Pharm; 1988 Jul; 7(7):514-27. PubMed ID: 3138063
[TBL] [Abstract][Full Text] [Related]
39. Recommendations for prophylaxis against Pneumocystis carinii pneumonia for adults and adolescents infected with human immunodeficiency virus.
MMWR Recomm Rep; 1992 Apr; 41(RR-4):1-11. PubMed ID: 1348843
[TBL] [Abstract][Full Text] [Related]
40. Comparison of trimethoprim-sulfamethoxazole, dapsone, and pentamidine in the prophylaxis of Pneumocystis carinii pneumonia.
Warnock AC; Rimland D
Pharmacotherapy; 1996; 16(6):1030-8. PubMed ID: 8947975
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
